RICHARD THOMAS LEE MD NPI 1316947385

NPI Information

  • NPI: 1316947385
  • Provider Name: RICHARD THOMAS LEE, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1415 OLD WEISGARBER RD STE 200
    KNOXVILLE, TN
    ZIP 37909
  • Phone: (865) 934-5800

Map and Directions

Get Directions

NPI Details

Richard Thomas Lee, MD is a hematology and oncology internal medicine in Knoxville, TN with 38 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Richard Thomas Lee, MD NPI is 1316947385. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE
Graduation Year:1988

The provider's business location address is:

1415 OLD WEISGARBER RD STE 200
KNOXVILLE, TN
ZIP 37909-341
Phone: (865) 934-5800
Fax: (865) 934-5800

The NPI 1316947385 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Iron level (HCPCS:83540)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Iron binding capacity (HCPCS:83550)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Magnesium level (HCPCS:83735)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Protein measurement, serum (HCPCS:84165)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Red blood count, automated test (HCPCS:85045)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Erythropoietin (protein) level (HCPCS:82668)
  • Folic acid level, serum (HCPCS:82746)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Uric acid level, blood (HCPCS:84550)

The enumeration date for this NPI number is 7/29/2005 and was last updated on 4/12/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyMD025486TENNESSEEYes
2207RH0003XInternal MedicineHematology & Oncology30403KENTUCKYNo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.